IP Verse

Janssen Pharmaceutica competitive analysis

Latest oppositions filed by Janssen Pharmaceutica

Explore patent oppositions filed by Janssen Pharmaceutica against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 9, 2026
Patent NumberTitleApplicantOpposition Date
EP3291679
Altering Microbial Populations & Modifying MicrobiotaSNIPRSep 14, 2022
EP3481838
Novel Processes For The Production Of OligonucleotidesGLAXOSMITHKLINEMay 19, 2021
EP2588167
Safety Device For A Pre-Filled Syringe And Injection DeviceSANOFI AVENTIS DEUTSCHLANDNov 21, 2018

Latest patents of Janssen Pharmaceutica opposed by its competitors

Explore Janssen Pharmaceutica's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 9, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3490560
Jan 22, 2025Methods Of Treating Prostate Cancer4
EP2234617
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters23
EP4005555
May 15, 2024Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations2
EP4025188
Jan 10, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations2
EP4025187
Jan 3, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations2
EP3744326
Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters10
EP3609497
Oct 12, 2022Combination Therapy For Prostate Cancer3
EP3311374
Jul 22, 2020Devices And Methods For Drug Administration And Mixing, And Training Of Proper Techniques Therefor2
EP3280416
Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters10
EP3087098
Apr 8, 2020Anti-Vista Antibodies And Fragments2

Latest PTAB cases involving Janssen Pharmaceutica

Discover the latest PTAB cases involving Janssen Pharmaceutica, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 12, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Janssen Pharmaceutica

IPR2020-00440Feb 7, 2020MYLAN LABORATORIESJANSSEN PHARMACEUTICAInstitution Denied
IPR2013-00365Jun 19, 2013HOSPIRAJANSSEN PHARMACEUTICALSInstitution Denied

Peer Comparison New

IP litigation analysis comparing Janssen Pharmaceutica with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 9, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JANSSEN PHARMACEUTICA165 - 1
GENERICS UK222 - - -
HAMM & WITTKOPP69 - - -
TEVA PHARMACEUTICALS218181712